amorphous calcium carbonate (AMOR 18) / Amorphical Ltd  >>  Phase 1
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
amorphous calcium carbonate (AMOR 18) / Amorphical Ltd
NCT02864784: Investigating the Safety, Tolerability and Efficacy of Amorphous Calcium Carbonate (ACC) on the Treatment of Subjects With CRPC

Withdrawn
1
60
RoW
Amorphous calcium carbonate, ACC, Placebo
Amorphical Ltd.
Castrate Resistant Prostate Cancer With Bone Metastasis
12/23
12/23
NCT03057314: Improving Function,Welfare of Late-stage Cancer Subjects by ACC

Terminated
1
10
RoW
Amorphous Calcium Carbonate, ACC
Amorphical Ltd.
Solid Malignancies, With or Without Lung Metastases
12/19
12/19
NCT03582280: The Effect of Amorphous Calcium Carbonate (ACC) Treatment on Function and Welfare in Late-stage Solid Cancer Subjects

Terminated
1
11
RoW
Amorphous Calcium Carbonate (ACC) - Amor
Amorphical Ltd.
Oncology
06/22
10/22

Download Options